In the news release, Global Citizen Solutions launches Global Atlas of Risk and Readiness 2026, issued 08-Apr-2026 by Global Citizen Solutions over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

Global Citizen Solutions launches Global Atlas of Risk and Readiness 2026

Size no longer guarantees readiness: new global ranking puts Switzerland and Singapore above US and UK

LONDON, April 8, 2026 /PRNewswire/ — Global Citizen Solutions (“GCS”), a leading residency and citizenship planning advisory firm, through its Global Intelligence Unit, has released the Global Atlas of Risk and Readiness 2026 (GARR), a new benchmarking framework assessing how effectively countries combine structural stability with long-term growth capacity across 85 jurisdictions.

The report introduces a dual-lens framework integrating risk exposure and forward-looking readiness, offering investors a structured basis for evaluating where capital is most likely to remain protected while compounding over time.

Top 5: Institutional strength defines global leadership

• Switzerland
• Germany
• Singapore
• Ireland
• Finland

These countries combine low structural risk with advanced readiness, including strong rule of law, innovation ecosystems, and deep capital markets. Europe dominates the upper tier, reflecting the premium placed on regulatory predictability, institutional depth, and regional integration. Switzerland leads on innovation and economic complexity; Germany tops the readiness ranking across the full dataset, reflecting industrial depth and human capital unmatched in the region.

The US paradox: world-leading readiness, structural risk drag

The United States presents the report’s most analytically striking case. It scores close to 90 on readiness — near the global frontier — reflecting deep innovation ecosystems, world-leading capital markets, and technological leadership. Yet it ranks only 24th overall. The report identifies the drivers as structural rather than cyclical: elevated public debt, political polarisation introducing regulatory unpredictability, and financial market sensitivity. High income and technological leadership, the data shows, do not automatically translate into balanced resilience.

Singapore: the scale argument, reversed

Singapore stands out as Asia’s only top-tier performer, ranking 3rd overall with a score of 92.60 demonstrating how strategic positioning and institutional coherence can compensate for limited scale. Singapore records the lowest risk score of any country in the dataset while ranking 11th globally on readiness, with the report classifying it as a global node of capital, innovation, and connectivity — a designation shared by no other Asian economy.

The UK holds, but faces headwinds

The United Kingdom ranks 21st globally with an overall score of 88.68. Classified as ‘Advanced and Stable’, it retains deep capital markets and strong institutional foundations, but neighbour Ireland’s 4th-place finish illustrates the premium the data places on deep regional integration and governance consistency — qualities the UK will need to demonstrate more fully to close the readiness gap.

“In today’s global economy, capital flows to resilience, and the data shows that institutional strength, not size, is the defining factor behind sustainable investment performance,” said Patricia Casaburi, CEO of Global Citizen Solutions.

The full GARR report is available at globalcitizensolutions.com.

BEIJING, April 8, 2026 /PRNewswire/ — SANY Heavy Industry (600031.SH, 06031.HK) reported its 2025 financial results. Revenue rose 14.73% year over year to $12.49 billion. Net profit attributable to shareholders climbed 41.18% to $1.18 billion. Net cash generated from operating activities came in at $2.80 billion, up 34.84% from a year earlier.

All major segments recorded growth. Revenue from excavators, the company’s core business, increased 13.73% year on year to $4.83 billion. Concrete machinery revenue rose 9.53% to $2.20 billion, while hoisting machinery revenue advanced 18.67% to $2.18 billion. Road machinery revenue grew 25.18% to $532 million. Piling machinery posted the fastest growth, with revenue jumping 35.81% to $392 million. Other segments generated $2.35 billion in revenue, up 13.28%.

The company’s net profit margin improved to 9.5%, up 1.7 percentage points from a year earlier, while robust operating cash flow underscored the resilience of its earnings quality.

International operations remained a key contributor to growth in 2025. Revenue from international markets reached $7.83 billion, up 15.14% year on year, accounting for 64% of total revenue. Growth was broad-based across regions: revenue in the Asia-Pacific rose 16.17% to $3.34 billion; Europe contributed $1.75 billion, up 1.50%; the Americas generated $1.56 billion, an increase of 8.52%; and Africa posted the strongest growth, with revenue jumping 55.29% to $1.16 billion.

SANY continued to build out its global R&D network, with centers worldwide, and introduced 60 new products for international markets in 2025. Its products are now sold in more than 180 countries and regions.

Growth was driven by demand in emerging markets and stable performance in developed markets, supported by a broader local operating footprint. Looking ahead, SANY is expected to maintain its focus on Globalization, Digitalization, and Decarbonization while continuing to broaden its portfolio in renewable energy and intelligent equipment.

Turnitin’s report shows a consistent percentage of “traditional” plagiarism, even in the age of AI

OAKLAND, Calif., April 8, 2026 /PRNewswire/ — Turnitin today released its first quarterly Learning Integrity Insights Report, which shares what the company is learning from educators, students, and institutions as they navigate responsible AI use. Based on global qualitative and quantitative data, Turnitin is hearing that many institutions have moved from detection to integration and have a desire for customizable AI to use in classrooms and lecture halls, recognizing that responsible use exists across a range of applications.

“There is no one-size-fits-all approach to what responsible use of AI in education looks like,” said Annie Chechitelli, Chief Product Officer at Turnitin. “Working with institutions on solutions that support their responsible AI use goals, we are gaining insights into what’s working, and what’s not. What we’re hearing from educators is that those who have integrated AI into their teaching want more customization and insight in how it can be used by their students. We are also hearing from both educators and students that their comfort with AI’s presence in feedback and grading is situation-dependent.”

Turnitin’s Learning Integrity Insights Report explores several themes on AI in education, including:

• From resistance to integration and personalization: “Responsible” use of AI is a range, in practice, for both students and educators.
  • More than 60% of recent customer feedback prioritized the need for transparency in AI use.
  • Most educators are not just asking whether AI was used; they’re asking how and why AI was used.
  • As educators and institutions move from detection, to integration of AI (with guardrails), there is a desire for customization to adjust the approved use of AI to the class or to the assignment.
• The feedback gap: Teachers tell us that they don’t have time to give students the amount of feedback students deserve. And students often don’t have time or the opportunity to ask for it during the writing process. AI could help here, but there is a healthy amount of hesitation around bringing AI into feedback.
• The policy gap: Conversations with customers reveal that when there are clear and consistent policies on the use of AI, both educators and students benefit. But fewer than half of institutions report having an AI policy.

While educators and students find their footing with the role of AI in the learning process and feedback and grading, “traditional” plagiarism still remains persistent with a consistent average of between 6-7% of student papers showing a similarity score of >80% from other sources.¹

As institutions, educators and students navigate the AI in the classroom, Turnitin remains committed to working alongside educators to deliver solutions that inspire authentic student learning while freeing up administrative time so educators can spend more time teaching. 

To explore the full Learning Integrity Insights Report, visit https://go.turnitin.com/turnitin-learning-integrity-insights-q1-2026.

Press Contact:
press@turnitin.com

About Turnitin
Turnitin stands with educators and institutions as champions of learning integrity who understand the enduring value of education in a rapidly changing world. As a global company with more than 16,000 customers in 185 countries and territories and more than 25 years of experience working closely with educators, Turnitin designs every product it builds to address timely needs in today’s learning settings. From integrity solutions offering transparency in the writing process to delivering secure high-stakes and course assessments, Turnitin provides educators and researchers with the tools they need to navigate responsible use of AI in education and the learning experience. Learn more at turnitin.com.

¹ From April 2023 to date, 6.16% of submissions contain >80% similarity, and of those, 91% primarily match other student papers, 7.8% match internet sources, and about 1% match publications. Before the release of generative AI tools over a similar three year period (11/30/2019 – 11/30/2022), a similarly consistent share of student papers showed extremely high overlap with existing sources. About 6.86% of submissions contained >80% similarity, and of those, 88.25% primarily matched other student papers, 10.75% matched internet sources, and about 1% matched publications.
⁴Jenay Robert and Mark McCormack. 2025 EDUCAUSE AI Landscape Study: Into the Digital AI Divide. Research report. Boulder, CO: EDUCAUSE, February 2025.

Milestones underscore clinical progress and strengthen commercial foundation

LOS GATOS, Calif., April 8, 2026 /PRNewswire/ — Supira Medical, Inc. (Supira), a clinical-stage company focused on transforming the percutaneous ventricular assist device (pVAD) market, today announced FDA approval to initiate the SUPPORT II Pivotal Trial. The trial is designed to support a future PMA submission and represents a critical step toward U.S. market entry.

SUPPORT II (SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)) is a prospective, randomized controlled study designed to assess the safety and efficacy of the company’s next-generation pVAD in patients undergoing HRPCI. The study will enroll up to 385 patients at up to 40 U.S. sites and is led by national co-principal investigators Dr. Ajay Kirtane, Professor of Medicine at Columbia University, Vagelos College of Physicians and Surgeons/New York-Presbyterian Hospital, and Dr. David Kandzari, Chief of the Piedmont Heart Institute and Chief Scientific Officer for Piedmont Healthcare, Atlanta, GA.

“In HRPCI, the decision to use hemodynamic support is often influenced by access, deliverability, and the balance between support and procedural efficiency,” said Dr. Kandzari. “A system that can provide effective circulatory support with a smaller profile has the potential to expand the available treatment population and improve effectiveness.”

“The appropriate use of a pVAD allows physicians to safely perform procedures of the highest complexity, offering HRPCI to patients who previously had limited options,” said Dr. Kirtane. “The initiation of this pivotal randomized trial of a novel, lower-profile hemodynamic support device is an important step in advancing the care of some of our highest risk patients.”

Advances in Cardiogenic Shock

Separately from SUPPORT II, the company has been pursuing opportunities to improve treatment options for patients experiencing cardiogenic shock. Recent case experience outside the U.S. includes the initial series of cardiogenic shock patients, utilizing percutaneous axillary access to enable patient ambulation with an active 10Fr pVAD.

Together, these milestones highlight what the next generation of temporary mechanical circulatory support can potentially enable; expanding access options, supporting mobility, and advancing how physicians manage critically ill patients.

For interventional cardiologists and heart failure specialists, full hemodynamic support with flexibility in percutaneous access site and the potential for patient mobility during support represent important steps toward improving the overall care pathway for cardiogenic shock.

Appointment of Medical Device Industry Veteran D. Keith Grossman as Independent Board Member

In parallel with these clinical milestones, Supira announced the appointment of D. Keith Grossman to its Board of Directors. Mr. Grossman’s 40-year leadership experience in the medical technology industry, including a foundational role in the mechanical circulatory support space, will reinforce the company’s focus on scaling toward market readiness and growth.

“Keith brings a valuable combination of operational discipline, commercial insights, and strategic perspective,” said Dr. Nitin Salunke, President and CEO of Supira Medical. “His addition as an independent member of our Board reflects our commitment to building an organization that is not only clinically differentiated but also positioned to execute at scale.”

“Supira has established a compelling clinical and technological foundation that is uniquely positioned to change the growing and still under-penetrated pVAD landscape,” said Mr. Grossman. “I look forward to supporting the company as it advances its pivotal trial and prepares to become a leading presence among treatment options for high-risk PCI and cardiogenic shock patients.”

About Supira Medical, Inc.

Supira Medical is focused on the development of a next-generation pVAD for use in high-risk patients undergoing interventional procedures and experiencing cardiogenic shock. To date, the Supira System has been used in 99 patients. To learn more about Supira Medical, please visit www.supiramedical.com.

pVADs are important for supporting cardiovascular function during HRPCI and in patients experiencing cardiogenic shock. HRPCI patients have complex coronary anatomy, compromised hemodynamics, and multiple comorbidities, while cardiogenic shock is a high-mortality condition where the heart is too weak to pump sufficient blood to vital organs, usually resulting from a heart attack or heart failure.

The Supira System is an investigational device and is not approved for sale in the U.S. or anywhere in the world. The device is limited by federal law to investigational use.

Media Contact:
Craig Brandli
VP of Marketing
craig@supiramedical.com

Conversational access to 150 years of interconnected scientific knowledge sets a new standard for trusted discovery

COLUMBUS, Ohio, April 8, 2026 /PRNewswire/ — CAS, a division of the American Chemical Society, today announced the launch of CAS Newton℠, science-smart agentic AI built specifically for scientific discovery. CAS Newton is grounded in published scientific knowledge curated by CAS scientists, drawing on more than 150 years of literature within the CAS Content Collection™ to ensure accuracy and scientific rigor.

By grounding AI‑generated insights in comprehensive, curated scientific knowledge, CAS Newton delivers reliable answers that help researchers confidently navigate ambiguity, conflicting results, and incomplete evidence to accelerate progress. Early user feedback reinforces the value of this approach, with three out of four respondents rating CAS Newton answers as more trustworthy than those from other AI tools.

“CAS provides the most authoritative, comprehensive, and rigorously curated chemistry data available,” said John Yates, Professor, Scripps Research Institute, speaking in his personal capacity. “Developing intelligent AI agents on top of this foundation will significantly expand access and improve efficiency. CAS Newton will empower users, transforming casual users into highly effective superusers.”

Based on user feedback, CAS Newton is considered the best agentic AI for science because it engages conversationally with complex scientific questions and carries context forward as inquiry evolves, grounded in published scientific knowledge curated within CAS data. Through follow‑up interactions, it refines questions and synthesizes results across multiple steps, lowering the barrier to accessing trusted scientific knowledge and helping researchers move from question to insight more efficiently while maintaining scientific rigor across disciplines.

• Extract new and greater insight from published science data: CAS Newton draws on the CAS Content Collection to connect concepts across chemistry, biology, materials science, and intellectual property.
• Save time and get reliable answers to accelerate decisions: Science-smart agentic workflows summarize large reference sets into concise insights and refine their approach as questions deepen.
• Make global scientific knowledge easily accessible: CAS Newton provides conversational access to the world’s published scientific knowledge without requiring specialized search expertise.

“The launch of CAS Newton marks a major shift in how scientific knowledge flows through discovery,” said Tim Wahlberg, Chief Product Officer and interim President, CAS. “CAS Newton pairs science‑smart agentic AI with the reliability and governance of the CAS Content Collection so researchers can move from question to grounded answers they can verify. It extends beyond a single interface, meeting teams where they work, including within secure environments that allow organizations to apply CAS Newton alongside proprietary data. This gives R&D leaders and researchers a practical path to innovate faster without compromising trust.”

R&D organizations can deploy CAS Newton within secure environments and integrate it alongside proprietary data through MCPs, APIs, and third‑party AI platforms. This approach enables teams to innovate using their own data while maintaining the reliability, governance, and trusted scientific foundation of CAS data across research workflows. In alignment with the CAS approach to ethical artificial intelligence, CAS Newton operates within a secure application boundary, ensuring no user input is shared outside the solution, and that queries and results are never used for cross-user model training.

Users can now access CAS Newton within CAS SciFinder^®, CAS BioFinder^®, and through a standalone CAS Newton interface. To learn more, visit the CAS Newton introduction page on cas.org.

About CAS

CAS connects the world’s scientific knowledge to accelerate breakthroughs that improve lives. We empower global innovators to efficiently navigate today’s complex data landscape and make confident decisions in each phase of the innovation journey. As a specialist in scientific knowledge management, our team builds the largest authoritative collection of human-curated scientific data in the world and provides essential information solutions, services, and expertise. Scientists, patent professionals, and business leaders across industries rely on CAS to help them uncover opportunities, mitigate risks, and unlock shared knowledge so they can get from inspiration to innovation faster. CAS is a division of the American Chemical Society. Connect with us at cas.org.

Media contact:
Joe Singh
Senior Communications Manager
CAS-PR@cas.org